Lumida
/GERN
⌘K
Geron Corp

Geron Corp

GERN
$1.44USD+1.41%+0.02 today

MARKET CAP

923.8M

P/E (TTM)

FWD P/E

46.3x

DAY RANGE

$1 – $1

52W RANGE

$1
$2

AI Summary

Stalk
StalkMedium

GERN is in a Stage 2 advance with a bullish medium-term bias confirmed by a Momentum Breakout and higher highs/lows. Yet price is now extreme overbought and extended well above the rising EMAs, so execution is deferred until shallow pullbacks into the 9/20/50 EMA support zone.

  • Q1 net revenue $51.8M (31% YoY), on track for $220–240M guidance
  • $341M cash position supports R&D spend and market expansion
  • Projected 2026 operating expenses of $230–240M accelerate cash burn
Full analysis →
Insider Trades8 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Feb 18, 2026SellGERNMichelle RobertsonEVP, CHIEF FINANCIAL OFFICER9,855$1.94$923.8M-28.36%+38.46%$19.1K-0.56%Stalk
Feb 27, 2025BuyGERNJohn A ScarlettChairman, President and CEO12,500$1.76$923.8M-28.36%+38.46%$22.1KStalk
Feb 27, 2025BuyGERNScott Alan SamuelsEVP, Chief Legal Officer15,000$1.61$923.8M-28.36%+38.46%$24.1K+128.40%Stalk
Feb 27, 2025BuyGERNJames ZieglerEVP, Chief Commercial Officer100,000$1.60$923.8M-28.36%+38.46%$160.0KStalk
Jul 8, 2024SellGERNAndrew J GrethleinEVP, Chief Operating Officer1,348,696$3.14$923.8M-28.36%+38.46%$4.2M+0.00%Stalk
Jun 10, 2024SellGERNFaye FellerEVP, Chief Medical Officer575,800$2.91$923.8M-28.36%+38.46%$1.7M+0.00%Stalk
Jun 10, 2024SellGERNAnil KapurEVP, Corp Strategy & CCO843,750$2.85$923.8M-28.36%+38.46%$2.4M+0.00%Stalk
Jun 4, 2024SellGERNJohn A ScarlettChairman, President and CEO1,200,000$3.27$923.8M-28.36%+38.46%$3.9M+0.00%10b5-1Stalk